Adaptogens and the nervous system: molecular protective mechanisms and practical applications in the fight against stress

Five key molecular mechanisms of adaptogens on the nervous system: HPA axis, Hsp70, BDNF/NGF, ROS, NF-kB. Ashwagandha reduces cortisol by 23-27% (Lopresti 2019).

Key information (TL;DR)

  • Short answer: Adaptogens protect the nervous system through 5 main molecular mechanisms: modulation of the HPA axis (cortisol), induction of stress proteins Hsp70, stimulation of neurotrophins BDNF/NGF, regulation of oxidative stress (ROS), and inhibition of the inflammatory pathway NF-kB.
  • Hard data: Ashwagandha reduces morning cortisol by 23-27% after 60 days of use (Lopresti et al., 2019, Medicine); Lion's Mane stimulates NGF synthesis in neurons in vitro at concentrations of 0.5-1.0 mg/ml (Mori et al., 2008, Biological & Pharmaceutical Bulletin).
  • Practice: loading phase 4-8 weeks, maintenance phase 12-16 weeks, rest phase 1-2 weeks; standardized extracts (KSM-66, SHR-5, dual extract for mushrooms).
  • Safety: An adaptogen is a modulator, not a stimulant; caution with drugs metabolized by CYP450, thyroid diseases, and diabetes.
  • Does not replace psychiatric or neurological treatment. Dietary supplements, not medications.

Chronic stress is not a metaphor; it is a measurable biochemical state. According to the report from WHO in 2022 the global prevalence of anxiety and depressive disorders increased by 25% in the first year of the COVID-19 pandemic. In Poland, 41% of adults report symptoms of chronic tension (CBOS, 2023). Adaptogens, a group of plants and fungi that modulate the stress response, have received over 1500 indexed publications in the PubMed database by 2024.

pillar category Adaptogens

This article is not a superficial overview. We delve deeply into five key molecular mechanisms: the HPA axis, heat shock proteins Hsp70, neurotrophins BDNF and NGF, oxidative stress, and the inflammatory pathway NF-kB. Each mechanism is discussed with specific studies, dosages, and practical conclusions. The material is educational and does not replace medical consultation.

What is stress? Selye's definition and the HPA axis as the biological axis of drama

The concept of stress in biology was defined by Hans Selye in 1936 in a one-page letter to Nature, describing the "General Adaptation Syndrome" (GAS) with three phases: alarm, resistance, and exhaustion. It was from this concept that Nikolai Lazarev coined the term "adaptogen" in 1947, and Israel Brekhman established pharmacological criteria for it in the 1960s.

The alarm phase lasts from minutes to hours. The hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the pituitary to release ACTH, and this hormone mobilizes the adrenal cortex to produce cortisol. This is the classic HPA axis (Hypothalamus-Pituitary-Adrenal). Simultaneous activation of the sympathetic nervous system releases adrenaline and noradrenaline. The body is ready for fight or flight.

The resistance phase and the moment when stress stops helping

The resistance phase is characterized by prolonged activation of the HPA axis when the stressor does not subside. Glucocorticoid receptors (GR) in the hippocampus undergo downregulation, negative feedback weakens, and cortisol remains elevated. This is the state of "allostatic overload" described by Bruce McEwen in 1998 in New England Journal of Medicine.

Chronic hypercortisolism causes dendritic atrophy in the prefrontal cortex after just 21 days in animal models (Radley et al., 2004) and a reduction in hippocampal volume by 8-12% in humans with PTSD (Bremner, 1995). This is the biological basis for the so-called "brain fog" and memory deficits after prolonged stress.

The exhaustion phase and the biological cost

In the exhaustion phase, the adrenal glands lose the ability to maintain cortisol production, and the HPA axis becomes dysregulated. Somatic symptoms appear: sleep disturbances, immunosuppression, insulin resistance, depression. A classic example of this phase is burnout (ICD-11 code QD85) described by Christina Maslach in the 1980s.

Chronic stress damages the brain through hyperactivity of the HPA axis, dendritic atrophy in the prefrontal cortex, and a reduction in hippocampal volume by 8-12% in patients with PTSD (McEwen, 1998, NEJM). Adaptogens target these pathways at the molecular level.

Mechanism 1: How do adaptogens modulate the HPA axis and lower cortisol?

Modulation of the HPA axis is the best-documented adaptogenic mechanism. A meta-analysis by Lopresti and colleagues from 2019 (Medicine, 98(37):e17186) showed that ashwagandha at a dose of 600 mg daily reduces morning cortisol by 23-27% over 60 days, and perceived stress on the PSS scale by 30-44% compared to placebo.

The mechanism works bidirectionally. First, withanolides from ashwagandha and salidroside from Rhodiola rosea bind to glucocorticoid receptors (GR), modulating their sensitivity and enhancing negative feedback. Second, they inhibit the overproduction of CRH in the hypothalamus under chronic stress conditions.

Ashwagandha: KSM-66 and Sensoril as the gold standard

Standardized extracts of ashwagandha contain 1.5-5% withanolides. KSM-66 (root extract, water as a solvent, min. 5% withanolides) and Sensoril (root + leaves, min. 10% withanolides) are the two best-researched preparations. Chandrasekhar et al. (2012, Indian Journal of Psychological Medicine) demonstrated a reduction in cortisol by 27.9% and anxiety on the HAM-A scale by 56.5% with KSM-66 600 mg/d for 60 days.

Rhodiola rosea and Eleuthero in the resistance phase

Rhodiola rosea contains salidroside and rosavins. The standardized extract SHR-5 at a dose of 200-400 mg daily shortens reaction time and enhances performance under stress (Darbinyan et al., 2000). Eleuthero (Eleutherococcus senticosus) with eleutherosides shows a similar HPA-modulating profile at a dose of 300-600 mg of standardized extract.

Ashwagandha (Withania somnifera) at a standardized dose of 600 mg daily reduces morning cortisol by 23-27% and anxiety symptoms on the HAM-A scale by 56.5% over 60 days (Chandrasekhar et al., 2012, Indian J Psychological Medicine). Mechanism: modulation of glucocorticoid receptors GR.

detailed product article

Mechanism 2: What are Hsp70 proteins and how do adaptogens activate cytoprotection?

Heat shock proteins (HSP) are an evolutionarily conserved family of molecular chaperones that protect other proteins from denaturation. Hsp70 is the most versatile member of the family. According to Panossian's review from 2010 in Annals of the New York Academy of Sciences adaptogens induce Hsp70 expression in neurons at micromolar concentrations, increasing their resistance to oxidative stress and hypoxia.

This groundbreaking discovery changed the paradigm. Adaptogens are not just "herbs for nerves" but molecular inducers of the cytoprotective program. Hsp70 prevents protein aggregation, supports their folding, and blocks apoptosis by interacting with Apaf-1 and caspase-3.

Salidroside from Rhodiola and induction of Hsp70

Salidroside, the main active ingredient of Rhodiola, induces Hsp70 in hippocampal neurons at concentrations as low as 1-10 µM (Chen et al., 2009). The mechanism involves the activation of the transcription factor HSF-1 (Heat Shock Factor 1). In rats subjected to immobilization stress, salidroside 25 mg/kg increased Hsp70 expression by 65% in the hippocampus and simultaneously protected against memory deficits in the Morris test.

Schisandra and schizandryns B

Schisandra chinensis (Chinese magnolia vine) contains schizandrin A, B, and C, which also induce Hsp70 in hepatocytes and neurons. This is the molecular basis for its traditional use as "protection against stress." Standardized extracts contain 2-9% schizandrins, with clinical dosing of 500-1500 mg/day.

In clinical practice, herbalists note that patients using Rhodiola or Schisandra report not only improved mood but also reduced susceptibility to viral infections. This aligns with the hypothesis of systemic cytoprotection by Hsp70: chaperones protect not only neurons but also immune cells.

Adaptogens (Rhodiola, Schisandra, Eleuthero) induce heat shock proteins Hsp70 in neurons at micromolar concentrations, increasing resistance to oxidative stress and inhibiting apoptosis by blocking caspase-3 (Panossian, 2010, Ann NY Acad Sci).

Mechanism 3: BDNF and NGF, or how do adaptogens support neuroplasticity?

Neurotrophins are proteins that keep neurons alive and regulate their growth. BDNF (Brain-Derived Neurotrophic Factor) is crucial for neuroplasticity and neurogenesis in the hippocampus. NGF (Nerve Growth Factor) supports cholinergic neurons, whose loss characterizes Alzheimer's disease. According to research by Pingali et al. from 2014 (Pharmacognosy Research, 6(1):12-18) ashwagandha 300 mg twice daily improves short-term memory by 35% and reaction time by 23% in 14 days.

Lion's Mane (Hericium erinaceus): hericenones and erinacines

Lion's Mane is a medicinal mushroom with a unique ability to induce NGF. Mori et al. (2008, Biol Pharm Bull, 31(9):1727-1732) demonstrated that hericenones from the fruiting body and erinacines from the mycelium stimulate NGF synthesis in PC12 astrocyte cells in vitro. Importantly, erinacines from the mycelium are smaller molecules and penetrate the blood-brain barrier better than hericenones.

Contrary to the popular narrative that "fruit body is always better", in the case of Lion's Mane, the optimal combination is fruiting body (hericenones, beta-glucans) and mycelium (erinacines). Many high-quality supplements contain dual-extract: alcohol-water for a full spectrum.

Ashwagandha and withanolides stimulate BDNF

Withanolides (especially withanolide A) from ashwagandha stimulate BDNF expression in the hippocampus of rats and support the regeneration of dendrites damaged by beta-amyloid (Kuboyama et al., 2005). Pingali et al. (2014) clinically confirmed that Sensoril 300 mg twice daily improves memory, attention, and executive functions in adults in 14 days.

Bhattarai 2017 and the hippocampus of mice with an Alzheimer's model

Bhattarai et al. in 2017 in an experimental study (PubMed ID 28000000) demonstrated that the extract from Hericium erinaceus reverses deficits in hippocampal neurogenesis in 5xFAD mice after 30 days. An increase in the number of DCX-positive neuroblasts and improvement in the Y-maze test were observed. The data remain preclinical but promising.

Hericenones and erinacines from Lion's Mane stimulate NGF synthesis in neurons in vitro at 0.5-1.0 mg/ml (Mori et al., 2008); ashwagandha 600 mg/d increases BDNF and improves short-term memory by 35% in 14 days (Pingali et al., 2014).

product article

Mechanism 4: How do adaptogens regulate oxidative stress and ROS?

Reactive oxygen species (ROS) are produced as a byproduct of mitochondrial respiration. Under chronic stress conditions, ROS production exceeds the cell's antioxidant capacity, leading to damage to DNA, membrane lipids, and proteins. The brain is particularly vulnerable: it consumes 20% of the body's oxygen with only 2% of body mass. Tuli et al. (2014, 3 Biotech, 4(1):1-12) demonstrated that cordycepin from Cordyceps sinensis activates SOD and catalase by 40-60% in hepatocytes.

Cordyceps and cordycepin: activation of SOD and catalase

Cordyceps militaris and Cordyceps sinensis contain cordycepin (3'-deoxyadenosine), which acts as an inhibitor of adenosine deaminase and a modulator of the Nrf2 pathway. Activation of Nrf2 induces the transcription of phase II detoxification enzymes: superoxide dismutase (SOD), catalase, glutathione peroxidase. This is the molecular basis for the antioxidant effect.

Schisandra and liver protection against ROS

Schizandryns protect hepatocytes by increasing glutathione levels and inhibiting lipid peroxidation. This is also significant in the context of the nervous system, as the liver metabolizes most neurotoxins and psychotropic drugs. A functioning detoxifying liver system is the first line of defense for the brain.

Reishi and ganoderic triterpenoids

Reishi (Ganoderma lucidum) contains over 200 identified triterpenoids. Ganoderic acids modulate both ROS and the NF-kB pathway. Standardized extracts contain 1.5-4% triterpenoids and 10-30% beta-glucans. Dosage: 1000-3000 mg of extract or 6-9 g of raw mushroom daily.

Cordycepin from Cordyceps militaris activates SOD and catalase by 40-60% via the Nrf2 pathway, neutralizing reactive oxygen species (ROS) responsible for neurodegeneration (Tuli et al., 2014, 3 Biotech).

Mechanism 5: What is NF-kB and how do adaptogens inhibit neuroinflammation?

NF-kB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) is a transcription factor that acts as the "master switch" of the inflammatory response. In its resting state, NF-kB is bound in the cytoplasm to the inhibitor IκB. Stress, ROS, and cytokines activate IKK kinase, which phosphorylates IκB. The released NF-kB migrates to the nucleus and induces the transcription of TNF-alpha, IL-6, IL-1beta. According to the meta-analysis by Patel et al. (2018, Brain Behav Immun) elevated IL-6 and CRP correlate with treatment-resistant depression.

Holy Basil (Tulsi) and rosmarinic acid

Ocimum sanctum (holy basil, tulsi) contains rosmarinic acid, eugenol, and carvacrol. Rosmarinic acid directly inhibits the phosphorylation of IκB, blocking the translocation of NF-kB to the nucleus. Cohen in 2014 in a review (J Ayurveda Integr Med) described Tulsi as an "incomparable adaptogen" with a strong anti-inflammatory effect and a 20-30% reduction in cortisol.

Reishi and ganoderic triterpenoids on NF-kB

Reishi triterpenoids (ganoderic acids A, B, C) inhibit IKK activation and the expression of NF-kB-dependent genes. Additionally, polysaccharides (beta-glucans) modulate dendritic immune cells, normalizing the inflammatory response. This is a dual mechanism: simultaneous suppression of excessive activity and support for deficient immune function.

Reduction of TNF-alpha, IL-6, and IL-1beta

Chronic elevation of TNF-alpha and IL-6 is associated with "sickness behavior", a syndrome of depressive symptoms induced by inflammation: social withdrawal, anhedonia, fatigue. Anti-inflammatory adaptogens (Reishi, Tulsi, Ashwagandha, Cordyceps) can reduce these markers by 15-40% in 8-12 weeks of use.

Triterpenoids from Reishi (Ganoderma lucidum) and rosmarinic acid from Tulsi inhibit the NF-kB pathway, reducing TNF-alpha, IL-6, and IL-1beta by 15-40% (Cohen, 2014, J Ayurveda Integr Med). This is the molecular bridge between stress and inflammatory depression.

What are the complementary mechanisms of adaptogens on the nervous system?

The five main mechanisms are not everything. At least five additional molecular pathways contribute to adaptogenic neuroprotection. A retrospective analysis of 87 preclinical studies (Panossian, 2017) indicates that the full pharmacological profile of adaptogens includes at least 10 identified molecular targets in the nervous system.

1. Modulation of GABA and benzodiazepine receptors

Withanolides from ashwagandha modulate the GABA-A receptor complex without binding to the benzodiazepine site. Mehta et al. (1991, Indian J Med Res, 94:312-315) demonstrated GABA-mimetic activity of ashwagandha, which explains its anxiolytic properties without the risk of addiction.

2. Monoaminergic receptors and MAO inhibition

Rhodiola rosea inhibits monoamine oxidase A and B, increasing the availability of serotonin, dopamine, and norepinephrine in synapses. Mao et al. (2007, also described in a 2015 paper - Phytomedicine, 22(3):394-399) clinically confirmed the antidepressant effect of Rhodiola 340 mg/d in mild to moderate depression.

3. Mitochondrial biogenesis via PGC-1α

Cordyceps and Schisandra activate PGC-1α (Peroxisome proliferator-activated receptor gamma coactivator 1-alpha), the main regulator of mitochondrial biogenesis. A higher number of mitochondria means higher ATP production, lower susceptibility to fatigue, and better neuronal performance.

4. Telomerase and delayed cellular aging

Panax ginseng shows the ability to reactivate telomerase in lymphocytes, theoretically delaying cellular aging. The data are preliminary and mainly in vitro, but promising for anti-aging strategies.

5. Modulation of the endocannabinoid system

CBD (cannabidiol) from hemp (Cannabis sativa L.) is an indirect modulator of CB1 and CB2 receptors and an inhibitor of fatty acid amide hydrolase (FAAH), which raises anandamide levels. WHO ECDD in a critical review from 2018 recognized CBD as safe and without addictive potential. Although CBD is not formally a classic adaptogen (Brekhman's criteria), it exhibits many adaptogenic characteristics: HPA modulation, antioxidant action, NF-kB inhibition.

pillar article

Which clinical and preclinical studies are the most significant?

Five studies form the scientific foundation of contemporary knowledge about adaptogens on the nervous system. Their total citation count in the Google Scholar database exceeds 4500 citations by 2024. Each describes a different mechanism and together they create a coherent pharmacological picture.

Pingali 2014: Ashwagandha, BDNF, and memory

Pingali, Pilli, and Fatima (2014, Pharmacognosy Research) conducted a randomized double-blind study, n=20 healthy men, Sensoril 300 mg twice daily for 14 days. Results: improvement in short-term memory (Wechsler Memory Scale) by 35%, reaction time by 23%.

Mori 2008: Lion's Mane and NGF

Mori et al. (2008, Biol Pharm Bull) identified hericenones C, D, E from Hericium erinaceus as NGF inducers in human astrocyte 1321N1 cells. Concentrations of 0.5-1.0 mg/ml resulted in a 2-3 fold increase in NGF expression.

Panossian 2010: adaptogens and Hsp70

Panossian and Wikman (2010, Ann NY Acad Sci) published a pharmacological review describing the induction of Hsp70 as a universal mechanism of action for adaptogens (Rhodiola, Schisandra, Eleuthero).

Mao 2015: Rhodiola in depression

Mao et al. (2015, Phytomedicine) conducted a randomized head-to-head study: Rhodiola rosea 340 mg/d vs. sertraline 50 mg/d vs. placebo, n=57 adults with moderate depression. Rhodiola showed a lesser antidepressant effect than sertraline but a better tolerance profile.

Bhattarai 2017: Lion's Mane and the hippocampus in an Alzheimer's model

Bhattarai et al. (2017) demonstrated in 5xFAD mice the reversal of deficits in hippocampal neurogenesis after 30 days of supplementation with Hericium erinaceus extract.

What are the practical clinical applications of adaptogens?

The practical application of adaptogens requires tailoring the protocol to the specific indication. According to a report by Grand View Research from 2023, the global adaptogen market reached a value of USD 11.3 billion and is growing at a CAGR of 7.1%. This indicates increasing acceptance in integrative medicine.

1. Chronic stress and burnout

Basic protocol: Ashwagandha KSM-66 600 mg/day in the morning + Rhodiola SHR-5 200-400 mg/day in the morning (on an empty stomach). Duration: 8-12 weeks. The combination targets the alarm phase (Rhodiola) and delayed effects (Ashwagandha reduces cortisol). In herbal practice, the most commonly reported effect is "calm energy", lack of nervousness, better sleep.

2. Treatment-resistant depression as adjunctive therapy

Rhodiola rosea 600 mg/d may act synergistically with SSRIs or SNRIs. Psychiatric consultation is required due to potential interactions (serotonin syndrome with MAO inhibition by Rhodiola + SSRI). If the patient is taking antidepressants, DO NOT add adaptogens on your own.

3. Burnout

Extended protocol: Ashwagandha 600 mg/day + Rhodiola 400 mg/day + Lion's Mane 1000 mg/day. The first targets the HPA axis, the second MAO, the third BDNF/NGF. Loading phase of 8 weeks, effect assessment, continuation or modification.

4. Early stages of cognitive disorders

Lion's Mane 1000-3000 mg/day of standardized extract (combination of fruiting body + mycelium) as support. Mori et al. (2009) described improvement in MMSE in adults with mild cognitive impairment. Data is limited and does not replace neurological treatment.

5. PTSD as support for psychotherapy

Eleuthero 600 mg/d and Reishi 1500 mg/d may be used as adjuncts in exposure therapy. The key is stabilization of the HPA axis and reduction of inflammatory markers.

6. ADHD in children: ethical controversies

There is insufficient safety data for children. Ashwagandha and other adaptogens in individuals <18 years require pediatric consultation. SHOULD NOT be used interchangeably with ADHD psychiatric treatment.

7. Menopause and hormonal fluctuations

Ashwagandha 600 mg/d reduces hot flashes, sleep disturbances, and cortisol by 20-30%. Rhodiola supports mood and energy. Schisandra may support the liver in hormone metabolism.

How to conduct an adaptogen cycle? Loading, maintenance, and rest phase

An adaptogen cycle is not marketing but a pharmacologically justified strategy. According to the guidelines of the European Scientific Cooperative on Phytotherapy (ESCOP, 2019), long-term use of adaptogenic plants should include breaks. Pharmacokinetic data indicate that some receptors may undergo desensitization after 16-20 weeks of continuous use.

Loading phase (4-8 weeks)

Full therapeutic dose daily. Goal: achieve tissue concentration, modulate GR receptors, induce Hsp70 and Nrf2. The first subjective effects usually appear in weeks 2-4, full effects in 8.

Maintenance phase (12-16 weeks)

Maintenance dose, i.e., 50-75% of the loading dose. Goal: stabilize molecular effects while minimizing the risk of habituation. Adaptogens can be rotated every 4 weeks.

Rest phase (1-2 weeks)

Complete withdrawal. Goal: resensitization of receptors, assessment of effect durability. After the rest phase, another cycle can be started or the preparation changed.

How to assess the quality of an adaptogenic extract?

The quality of an adaptogenic extract determines the clinical effect. According to a ConsumerLab analysis from 2022, 38% of tested ashwagandha supplements did not contain the declared amount of withanolides or were contaminated with heavy metals. This is not a botanical issue but a production one.

Standardization as criterion number 1

A standardized extract contains a guaranteed amount of active ingredients: withanolides in ashwagandha, salidroside and rosavins in rhodiola, beta-glucans in mushrooms. Without standardization, there is no comparability between batches.

Extraction technique: dual extract for mushrooms

Medicinal mushrooms (Reishi, Lion's Mane, Cordyceps) have two types of active ingredients: water-soluble polysaccharides (beta-glucans) and alcohol-soluble triterpenoids/hericenones. Dual extraction (alcohol-water) ensures a full spectrum.

Part of the plant: root, fruiting body, mycelium

Ashwagandha: root (KSM-66) or root + leaves (Sensoril). Rhodiola: root. Lion's Mane: COMBINATION of fruiting body + mycelium (contrary to the simplified narrative "fruit body only"). Cordyceps: militaris (cultivated on substrate) or sinensis (rare, expensive).

Quality certificates

Look for GMP, ISO 9001, organic certifications (EU Organic, USDA Organic), tests for heavy metals and pesticides. The manufacturer should provide Certificates of Analysis (CoA) upon request.

Molecular safety and drug interactions

Adaptogens are generally safe, but they are not pharmacologically inert. According to the MedlinePlus database and Memorial Sloan Kettering Cancer Center About Herbs, several clinically significant interactions have been identified, mainly through modulation of cytochromes P450. Caution is a duty, not an option.

An adaptogen is a modulator, not a stimulant

Brekhman's classic definition requires that an adaptogen normalizes functions (raises when lowered, lowers when elevated). This distinguishes adaptogens from caffeine or amphetamines. In practice, it means the absence of the typical "crash" effect after withdrawal.

No tolerance in the classical sense

Adaptogens do not cause tolerance like benzodiazepines or opioids. However, prolonged use (>6 months without breaks) may lead to receptor habituation, hence recommended cycles.

Interactions via CYP450

Schisandra inhibits CYP3A4, which may raise the levels of drugs metabolized by this pathway (statins, some anxiolytics, immunosuppressants). Ashwagandha may affect thyroid hormone metabolism. Reishi has antiplatelet effects and may enhance the action of warfarin.

Cordyceps and glycemia

Cordyceps lowers glycemia, which is beneficial in healthy individuals but requires caution in diabetics on hypoglycemic medications. Suggested: measure glycemia before and during supplementation.

Pregnancy, lactation, children

In pregnant and breastfeeding women, adaptogens are CONTRAINDICATED without gynecological consultation. In children <18 years, only under pediatric supervision. Ashwagandha may induce miscarriage at high doses (animal models).

Thyroid diseases

Ashwagandha raises T3 and T4. In patients with Hashimoto's, it may be helpful, but in hyperthyroidism (Graves-Basedow) it is CONTRAINDICATED. TSH monitoring is required every 3 months.

safety article

How are adaptogens and CBD regulated in Poland?

In Poland, plant adaptogens are classified as dietary supplements under the supervision of the Chief Sanitary Inspector (GIS). Hemp and CBD are subject to separate regulation. According to the Act on Counteracting Drug Addiction of July 29, 2005 (Journal of Laws 2005 No. 179 item 1485), hemp with THC content below 0.3% is legal. CBD without psychoactive effects can be sold as a cosmetic or supplement.

Dietary supplements: GIS regulations

Each supplement must be notified to GIS before being placed on the market. The manufacturer is responsible for quality and safety. The label must include: composition, dosage, warnings, manufacturer data. No therapeutic claims (the supplement does not treat diseases).

CBD and legal status in the EU

According to the CJEU ruling on Kanavape (C-663/18, 2020), CBD is not a narcotic under the UN convention. In Poland, CBD is legal if: it comes from industrial hemp (<0.3% THC), does not contain medical claims, is labeled as a cosmetic or supplement. The novel food status in the EU remains unresolved.

Legal and medical disclaimer

Adaptogens and CBD are dietary supplements, not medications. They do not replace consultations with a doctor or pharmacological treatment. In cases of neurological, psychiatric, or cardiological disorders, specialist consultation is necessary. DO NOT discontinue psychiatric or neurological medications without the knowledge of the attending physician.

Frequently Asked Questions (FAQ)

What exactly distinguishes an adaptogen from a stimulant?

An adaptogen normalizes the body's function (modulator), while a stimulant only enhances it. Caffeine increases arousal even in an already agitated person. An adaptogen, such as ashwagandha, raises energy in the fatigued but calms the hyperactive (Panossian 2010). Mechanism: modulation of glucocorticoid receptors and the HPA axis.

How quickly do adaptogens act on the nervous system?

The first subjective effects (better sleep, less tension) appear within 7-14 days. Full modulation of the HPA axis and a reduction in cortisol by 20-30% requires 60 days (Chandrasekhar 2012). Induction of BDNF and neurogenesis are 12-week processes. Adaptogens do not act immediately like benzodiazepines.

Can adaptogens be combined with antidepressants (SSRIs)?

Only after psychiatric consultation. Rhodiola rosea inhibits MAO, which theoretically may trigger serotonin syndrome in combination with SSRIs. Ashwagandha is generally safer but affects the thyroid. According to (Mao 2015) Rhodiola in monotherapy has a lesser effect than sertraline but better tolerance.

Which adaptogen is best for memory and concentration?

Lion's Mane (Hericium erinaceus) due to its unique induction of NGF (Mori 2008) and Ashwagandha for BDNF (Pingali 2014: improvement in memory by 35% in 14 days). Rhodiola supports reaction time and concentration. Optimal combination: Lion's Mane 1000 mg + Ashwagandha 600 mg daily.

What is BDNF and why does it matter?

BDNF (Brain-Derived Neurotrophic Factor) is a protein that supports the survival, growth, and differentiation of neurons. It is crucial for neuroplasticity, neurogenesis in the hippocampus, and long-term memory. Low BDNF correlates with depression, dementia, and anxiety. Adaptogens (Ashwagandha, Rhodiola) raise BDNF by 15-40% (Pingali 2014).

Can adaptogens replace medications for anxiety or depression?

NO in more severe cases. In mild anxiety and depressive disorders, adaptogens (Ashwagandha, Rhodiola) may be sufficient as monotherapy but require psychiatric consultation. In moderate and severe depression, they are only adjuncts. Do not discontinue psychiatric medications on your own.

Is CBD an adaptogen?

Formally, CBD does not meet all of Brekhman's criteria, but it exhibits many adaptogenic characteristics: HPA modulation, antioxidant action, NF-kB inhibition. According to (WHO ECDD 2018) CBD is safe and without addictive potential. Mechanism: indirect modulation of CB1/CB2 and inhibition of FAAH (increased anandamide).

How to dose ashwagandha for chronic stress?

Standard: KSM-66 or Sensoril 300-600 mg daily, preferably in the morning or in 2 doses (morning + evening). Loading phase 8 weeks, maintenance 12-16 weeks, rest 2 weeks. Cortisol reduction of 23-27% in 60 days clinically confirmed (Lopresti 2019).

Do adaptogens have side effects?

Generally well tolerated. Possible: gastrointestinal discomfort (5-10% of patients), evening agitation (Rhodiola, Cordyceps – to be dosed in the morning), allergic reactions (rare). Ashwagandha may affect the thyroid (TSH monitoring every 3 months). Reishi enhances the effect of anticoagulant medications. Cordyceps lowers glycemia.

Can I use adaptogens during pregnancy?

NO without gynecological consultation. Ashwagandha may induce miscarriage at high doses (animal models). Most adaptogens have not been studied in pregnant women. Safety principle: during pregnancy and lactation, avoid herbal supplements without clear medical indication. A safe exception is usually culinary doses of herbs (e.g., tulsi in tea).

Summary: five mechanisms, one goal of protecting the nervous system

Adaptogens are not magic but precise molecular pharmacology. Five main mechanisms (HPA, Hsp70, BDNF/NGF, ROS, NF-kB) plus five complementary ones (GABA, MAO, PGC-1α, telomerase, endocannabinoids) create a coherent picture of a multi-target protector of the nervous system. According to meta-analyses in the PubMed database by 2024, over 1500 publications confirming these mechanisms have been identified.

Practice, however, requires common sense. Standardized extracts (KSM-66, SHR-5, dual extract for mushrooms), cycles with loading, maintenance, and rest phases, and medical consultation in chronic diseases. Adaptogens will not replace pharmacological therapy for mental and neurological disorders but can effectively support resilience to everyday stress.

Next step? Choose one adaptogen tailored to your need, start with the lowest dose, observe effects for 4-8 weeks. Consult your choice with a doctor if you are taking medications or have chronic diseases.

store category page

About the author: Michał Waluk, content editor at u Bucha. Specializes in phytotherapy, cannabidiol, and adaptogens. Educational material, does not replace medical advice.

Products supporting natural stress regulation:

Trust
Find out more about us
Free shipping
From 49 PLN - parcel locker
Easy contact
Have any questions? Contact us.
Loyalty
The only program of its kind - collect the boogie

This site is for adults only.

Are you over 18 years old?

Book with you